grow in the usual cultures. Because the genus Malassezia cannot synthesize long-chain fatty acids, the culture needs to be plated on a Sabouraud dextrose agar that is supplemented with a source of free fatty acids, such as sterile olive oil. It should be incubated at 34 to 37°C, and it takes 2 to 4 days to grow. It is seen easily on a buffy coat Gram's stain. Also, samples taken from the indwelling line will likely have a higher yield than those from peripheral draws. 14 If involvement of the endocardium or great central veins is suspected, a transesophageal echocardiogram is the test of choice.
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Optimal treatment for M furfur sepsis in adults is unclear. Of the cases reported, two had their central lines removed, and both recovered. Three patients whose parenteral lipids were simply discontinued also recovered. Of the three adults who received amphotericin B in addition to stopping the lipid alimentation, one had persistent fungemia and died of a cardiac arrest. Two patients who were treated with amphotericin B while leaving the CVC in place soon died of their underlying diseases. The one patient who did not have an indwelling catheter and did not receive lipid infusions was also treated with amphotericin B and did recover.
M furfur sepsis is an uncommon infection in adults receiving chronic TPN, and we have presented the first adult to have M furfur fungemia complicated by a septic thrombus extending into the right atrium. In the patient with a CVC who is receiving hyperalimentation with lipids, this entity needs to be considered in the fever workup. A buffy coat should be done on peripheral smears, and cultures should be empirically supplemented with olive oil. The treatment should at least include the discontinuation of the IV lipids and possible removal of the line. If either the superior vena cava or endocardium is involved, amphotericin-B therapy and possibly surgical debridement are warranted. We successfully used argon plasma coagulation (APC) and tranilast to treat granulation tissue that had formed on an end-to-end tracheal anastomosis. APC had several advantages over laser in the management of exuberant granulation tissue, and we considered tranilast to be effective in our patient. To our knowledge, this is the first description of the use of APC in the management of anastomotic granulation tissue in the trachea or bronchus.
References
(CHEST 2000; 118:1829 -1831)
Key words: argon plasma coagulation; granulation tissue; tracheal anastomosis; tranilast Abbreviation: APC ϭ argon plasma coagulation E xcessive growth of granulation tissue at anastomosis is a common postoperative complication. It can lead to airway stenosis, obstruction, and fatal pulmonary infection. 1 Many treatment methods have been reported, including bronchoscopic debridement, laser therapy, electrocautery, and stent placement. However, controlling and treating the formation of granulation tissue in the airway is difficult. 2 Argon plasma coagulation (APC) is a special surgical technique that uses high-frequency electric current for thermal coagulation and devitalization of biological tissue. APC gives a controlled, limited penetration into the tissue and good control of bleeding. It has already proved its value in open surgery, and use of it in GI endoscopy began in 1994. 3, 4 Tranilast, an antiallergic agent, has been used to prevent hypertrophic scars and keloid. We considered that tranilast could help prevent granulation tissue overgrowth in the trachea.
In this report, we describe the successful use of APC and tranilast in the management of exuberant granulation tissue arising from a tracheal anastomosis.
Case Report
A 29-year-old woman was admitted to our hospital for tracheoplasty. She had had a traffic accident on June 16, 1990, when she was 21 years old. She had been intubated, and a tracheostomy had later been performed. By October 1990, her respiration had recovered fully, but tracheal stenosis caused by granulation tissue was recognized with MRI and flexible bronchoscopy. Several attempts were made to remove the granulation tissue with a Nd-YAG laser, but it had soon regrown; 7 years after the accident, a T tube had been inserted. In April 1998, the woman came to our hospital for surgical treatment. Tracheal threedimensional CT demonstrated the stenosis and the stoma (Fig 1) .
On June 23 1998, we resected a 3.7-cm-long section of the patient's trachea, from the second to the ninth tracheal ring, and performed an end-to-end anastomosis. Two weeks later, flexible bronchoscopy revealed a small amount of granulation tissue forming in the cartilaginous portion of the anastomosis (Fig 2, a) . The patient was prescribed tranilast, 300 mg/d, not only to stop the surgical scar enlarging, but also to inhibit the growth of granulation tissue. She was discharged 28 days after surgery with no respiratory problems. She was followed-up as an outpatient, and continued to receive tranilast. In August and October of 1998 (at 2 months and 4 months after surgery), we observed excessive growth of anastomotic granulation with a flexible bronchoscope (Fig 2, b and c) . On each of these occasions, we resected the granulation tissue with several short bursts of APC. The equipment for APC consists of the APC probe, an argon-gas source, and a high-frequency surgical unit (APC 300, ICC 350; Erbe Elektromedizin; Tuebingen, Germany). To deliver the gas, we used a flexible Teflon tube with an outer diameter of 2.0 mm; this was put into the working channel of the flexible bronchoscope. After the second APC treatment (5 months after the surgery), the anastomotic granulation tissue had completely disappeared (Fig  2, d) granulation tissue had not recurred, and no stenosis was visible in the trachea on three-dimensional CT (Fig 3) .
Discussion
The major complications of tracheal and bronchial anastomosis performed for either transplantation or sleeve resection include early leakage, fistula formation, granulation tissue formation, and stenosis. In the case of airway stenosis caused by the formation of exuberant granulation tissue, approaches have included electrocautery, mechanical dilatation, laser phototherapy, cryotherapy, and placement of wire or silicon stents. 2 Among these therapies, Nd-YAG laser phototherapy has often been reported for the treatment of benign, inflammatory stenosis because it gives excellent immediate and short-term results. 1, 5 However, its use in a flexible bronchoscope in the airway is limited by the fact that the rate of transition between coagulation and vaporization depends on the distance from the tip to the tissue. 6 Because it is difficult to keep this distance constant, the vaporization depth is difficult to control and the thermal effect cannot be predicted. The surgeon must take extreme care in order to avoid creating a bronchomediastinal fistula.
APC has been used in open surgery for treating superficial hemorrhages from parenchymal organs. It is only recently that it has been introduced into flexible endoscopy. 4 APC has already been shown to be an efficient tool for endoscopic treatment of GI neoplasms and bleeding, and is now undergoing trials in various surgical fields. 7 APC has also been used in the bronchoscopic treatment of benign or malignant lesions in the airway. 6 The highfrequency electrical current is fed from a probe tip through the ionized argon gas without contact with the tissue, resulting in superficial, thermal coagulation. Since argon is chemically inert, there is no tissue carbonization. It is very effective for hemostasis, and the brightly shining ionized argon plasma can be guided under visual control. The penetration depth of about 2 mm is constant and predictable, and the controlled depth of penetration limits thermal trauma, thus avoiding unnecessary damage of the airway cartilage and connective tissue. The absence of the vaporization effect is complemented by the fact that APC desiccates the tissue, thus preventing hazardous perforations. Theoretically, the susceptibility of tissue to APC depends on its water content; therefore, mucous membranes and fresh granulation tissue are more sensitive to APC than cartilage and connective tissue because they have a higher water content. APC also has the advantages of mobility and a lower cost than other common treatment modalities.
Recurrence is often encountered after treatment of granulation tissue. Platelet-derived wound-healing formula has been used to treat bronchial obstruction after lung transplantation, in combination with Nd-YAG laser phototherapy. 8 This formula releases ␣-granules from platelets. These granules contain locally acting growth factors and promote epithelialization of the bronchial anastomosis. Tranilast, an antiallergic agent, is used to prevent hypertrophic scars and keloid. It inhibits morphologic change of fibroblasts into myofibroblast-like cells and also inhibits their proliferation by suspending the cell cycle at the G0/G1 phase. 9 In our case, granulation tissue grew despite the initial tranilast treatment; however, the connection between the granulation tissue and the trachea diminished at the second treatment and completely disappeared after that. We considered that tranilast helped prevent granulation overgrowth in our patient. Tranilast is accessible and cost-effective compared with plateletderived wound-healing formula.
We believe that APC is an effective and useful treatment for granulation tissue formation at tracheal or bronchial anastomosis. 
